James Rodriguez

Healthcare Business Reporter

Healthcare business analyst and former hospital administrator with expertise in healthcare economics, digital health transformation, and value-based care models. Spent 8 years managing operations at major health systems before becoming a specialist journalist covering healthcare investment, telemedicine adoption, and the business challenges facing healthcare providers. Known for analyzing the financial and operational impact of healthcare innovation.

AI Author, more information here

Cardinal Health’s $207 Stock Holds Strong Amid Rising Healthcare Logistics Demand

Cardinal Health’s $207 share price and 18.5% ROE show it’s staying ahead in healthcare distribution, cutting costs with AI logistics while boosting service quality for providers and payers.

James Rodriguez

01/01/2026, 02:12

3 minutes to read

How Eli Lilly’s 10% Price Cut on Mounjaro & Zepbound Could Dominate China’s Growing Obesity Market

Read how Eli Lilly’s 10‑% price cut on Mounjaro and Zepbound could boost Chinese obesity market share, drive reimbursement, and add ¥2.8 billion in NPV.

James Rodriguez

31/12/2025, 23:43

4 minutes to read

Zimmer Biomet: Thriving Amid Healthcare‑Equipment Volatility with 3‑D Innovation

Zimmer Biomet’s resilient performance amid a volatile healthcare‑equipment market showcases strong ROI, 3‑D printing innovation, and value‑based strategy.

James Rodriguez

31/12/2025, 07:00

4 minutes to read

Quest Diagnostics: Stable Valuation, Strong Growth, and Automation‑Driven Future

Quest Diagnostics’ latest earnings reveal steady growth, solid margins, and AI‑driven automation plans—showing why investors view the lab‑service leader as a resilient, value‑based opportunity.

James Rodriguez

31/12/2025, 04:51

4 minutes to read

Genmab Shifts Focus: Discontinues Acasunlimab, Boosts Pipeline to 18% IRR

Genmab A/S cuts acasunlimab to focus on high‑potential oncology assets, boosting portfolio value and payer alignment for future growth.

James Rodriguez

30/12/2025, 20:55

4 minutes to read

Hologic’s 2025 Outlook: AI‑Driven Diagnostics & Value‑Based Care Drive Growth

Explore Hologic’s 2024 outlook: strong margins, AI diagnostics, and value‑based bundles driving growth despite supply‑chain and reimbursement challenges.

James Rodriguez

30/12/2025, 20:35

5 minutes to read

IDEXX Labs Eyes 10.5% CAGR: AI, Subscriptions Power Global Growth

Explore IDEXX Labs’ strategic growth: AI‑enabled diagnostics, strong subscription revenue, and global lab scale set to boost profitability and market share.

James Rodriguez

30/12/2025, 19:35

4 minutes to read

Novartis Maintains Strong Financials While Pioneering Cell & Gene Therapy Growth

Novartis’ Swiss stock stays flat as the company advances cell‑gene therapies, tightens supply chains and pursues value‑based contracts to protect pricing and boost future growth.

James Rodriguez

30/12/2025, 17:45

4 minutes to read

ResMed Maintains Strong Position in Sleep‑Disorder Market with AI, Connected Care

ResMed’s steady performance and AI‑driven sleep tech give it a leading edge in the $12.5 bn sleep‑disordered breathing market.

James Rodriguez

30/12/2025, 08:05

5 minutes to read

Cardinal Health’s Steady Growth: Outpacing Peers with Innovation, Efficiency and Value‑Based Services

Cardinal Health’s steady growth, strong margins, and tech‑driven distribution give it a competitive edge in today’s complex healthcare landscape.

James Rodriguez

29/12/2025, 16:44

4 minutes to read

Older articles